The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
November jobless rate drops to 3.36%, 3rd straight monthly fall
12/23/2024 10:17 PM - Society
Two Hong Kong passengers injured in Taichung bus accident
12/23/2024 09:43 PM - Business
TRC could see NT$12 billion loss in 1st year as company
12/23/2024 09:32 PM - Science & Tech
Taiwan, Japan present joint research findings on shortfin mako shark
12/23/2024 08:40 PM - Business
Industrial production up for 9th straight month in November
12/23/2024 08:17 PM